Electrophoresis Market Overview and Introduction

Global Electrophoresis Market is anticipated to grow at a 5.3% CAGR from 2019 to 2030.

Electrophoresis is a technique which utilizes an electric field to separate charged particles, namely DNA, and other macromolecules like proteins and RNA, based on charge and size. This process is performed by utilization of a pair of electrodes generating an electric potential (E), which helps in migration of charged particle towards its respective poles. Electrophoresis is used for several applications, namely separation of proteins, nucleic acids, visualization of molecular markers, verification of amplification by PCR, separation of DNA fragments, and to check quantity and quality of genomic DNA.

The global electrophoresis market is driven by rapid growth of geriatric population, and increasing infectious diseases, cancer and genetic disorders worldwide. Moreover, increasing use of Next Generation Sequencing (NGS), growing number of laboratories for the purpose of forensic, clinical and research studies, coupled with increasing funding for research in the fields of proteomics and genomics have been crucial in contributing to the growth of this market. However, limited sample analysis and time-consuming operations are likely to restrain the market to a certain extent.

Electrophoresis Market by Product

On the basis of product, the electrophoresis market is segmented into systems, reagents, software and gel documentation systems. The segment of systems can be further segmented into gel electrophoresis systems, agarose gel electrophoresis and polyacrylamide gel electrophoresis. Whereas, the capillary electrophoresis can be segmented into capillary zone electrophoresis, capillary isoelectric focusing, capillary isotachophoresis, capillary gel electrophoresis, micellar electrokinetic capillary chromatography and capillary electrochromatography. In terms of revenue, the reagents segment was estimated to account for the largest market share, owing to incessant demand of these products for laboratory applications.

Electrophoresis Market by Applications

Similarly, the segment of applications can be broadly classified into quality control & process validation, research and diagnostic. The segment of research was estimated to dominate the majority of the market share in 2018, attributing to factors such as increasing adoption of electrophoresis for drug discovery, and technological advancements among others.

Electrophoresis Market by End Users

Finally, based on the end users, the market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies and other end users. The academic & research institutes segment is estimated to account for the largest share of the global electrophoresis market. The large share of this segment can be attributed to increasing spending in R&D, goring investments and funding from both public & private sectors and rising number of research studies in the field of biotechnology, drug discovery and life sciences among others.

Electrophoresis Market by Regions

The global electrophoresis market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated this market , followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such as increasing incidences of infectious diseases, cancer and genetic disorders, growing research projects involving genes, biomolecules & proteins, and rising focus on drug development. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, Korea, Japan and India. Factors such as favorable government regulations, increasing funding in the field of R&D and improving research infrastructure is anticipated to be critical in the development of the global market in this region.

Electrophoresis Market Prominent Players

The prominent players in the global electrophoresis market are SEBIA, Harvard Bioscience, Merck KGaA, QIAGEN, PerkinElmer Inc., Danaher, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., GENERAL ELECTRIC COMPANY, and Bio-Rad Laboratories, Inc. among others